Acute myeloid leukaemia: Focus on FLT3-ITD mutation | ESMO
ESMO World Congress on Gastrointestinal Cancer 2018 | World GI
Thanks to all! | ESMO
Gustave Roussy at the ESMO 2018 Congress | Gustave Roussy
ESMO 2018 Munich | ACS
ESMO 2018 Congress | HealthManagement.org
Trastuzumab Biosimilar for Tomorrow | ESMO
Gustave Roussy at the ESMO 2018 Congress | Gustave Roussy
ESMO 2018 Munich | ACS
ESMO 2018
ESMO 2018 - Corporate Lightboxes | European Society for Medical Oncology | Flickr
Ovarian news from ESMO 2018: SOLO-1 results for olaparib - YouTube
A look ahead to key trial readouts at ESMO - PMLiVE
ESMO 2018 Congress TV – Day 1 Highlights - YouTube
ESMO 2018, the European Society for Medical Oncology | Weichlein Tours
Changing the Natural History of Breast Cancer: Where are We, and What's Next in HER2-Positive and Triple-Negative Disease? | ESMO
ESMO 2018 Congress | About Event | Hospitals Management
Esmo 2018 – Recapping a wild weekend | Evaluate
The Congress of European Society for Medical Oncology is taking place in Munich from 19 – 23 Oct 2018. This year, three abstracts of SAKK trials have been accepted for poster sessions.
Congress Coverage | oncinfo
CDK Inhibitor Therapy in HR-Positive/HER2-Negative Advanced Breast Cancer Clinical Characteristics and Choices | ESMO
Esmo 2018 – Roche misses the bullseye in triple-negative breast cancer | Evaluate
ESMO 2018 Congress | Munich, Germany
Immunotherapy in Daily Clinical Practice: Clinical Application and Emerging Opportunities | ESMO
Nature Conferences в Twitter: „In Munich for ESMO 18 Congress? Stop by Room MR B42 for our Nature Cafe on Real-World Evidence in Clinical Practice with these oncology experts! Register today: https://t.co/fi8dYwXMMY #
